Clarifying COVID-19 (aka yes, cuz all these sites want to hurt people 🙄)

Clarifying COVID-19 (aka yes, cuz all these sites want to hurt people 🙄)

398 bookmarks
Newest
The Role and Safety of Aluminum Adjuvants in Childhood Vaccines | Pediatrics | American Academy of Pediatrics
The Role and Safety of Aluminum Adjuvants in Childhood Vaccines | Pediatrics | American Academy of Pediatrics
Aluminum salts have been used as adjuvants in vaccines for nearly a century, enhancing the immune response to purified antigens and ensuring durable protection against serious infectious diseases. Despite their longstanding record of safety and effectiveness, aluminum adjuvants have become a focus of public concern, with claims linking them to developmental, neurologic, allergic, and autoimmune diseases. This review summarizes the immunologic rationale for aluminum adjuvants and evaluates the evidence for proposed safety risks. Aluminum salts have consistently been demonstrated over nearly a century of use to enhance the immune responses elicited by vaccines while also being well-tolerated by nearly all who take them. Pharmacokinetic studies show that aluminum released from intramuscular vaccines is slowly absorbed and efficiently cleared by the kidneys, contributing minimally to systemic levels. Large-scale clinical and epidemiologic studies consistently demonstrate no association between aluminum-adjuvanted vaccines and autism spectrum disorder, neurotoxicity, allergic disease, or autoimmune disease. Clinically, vaccines adjuvanted solely with aluminum salts generally do not result in systemic reactogenicity, though local reactions are common. Collectively, the evidence strongly supports the safety of aluminum adjuvants and their necessity in certain vaccines. Clinicians can reassure caregivers that aluminum-containing vaccines provide clear benefits, with risks largely limited to transient local reactions and no systemic toxicity signal in large clinical and epidemiologic studies.
·publications.aap.org·
The Role and Safety of Aluminum Adjuvants in Childhood Vaccines | Pediatrics | American Academy of Pediatrics
Cancer patients who got a COVID vaccine lived much longer
Cancer patients who got a COVID vaccine lived much longer
A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy lived dramatically longer than those who didn’t. Researchers from the University of Florida and MD Anderson Cancer Center discovered that the vaccine’s immune-activating properties may boost cancer-fighting responses, acting like a nonspecific “flare” that reawakens the immune system.
·sciencedaily.com·
Cancer patients who got a COVID vaccine lived much longer
Scientists discover COVID mRNA vaccines boost cancer survival
Scientists discover COVID mRNA vaccines boost cancer survival
Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing immunotherapy. The vaccine appears to prime the immune system in a powerful, nonspecific way, enhancing cancer treatment outcomes. If confirmed, the discovery could lead to a universal cancer vaccine and transform oncology care.
·sciencedaily.com·
Scientists discover COVID mRNA vaccines boost cancer survival